Medrio Client Stories

  1. Atlantic Research Group Builds Competitive Advantage With Medrio EDC 1/30/2023

    By using Medrio’s EDC platform, learn how Atlantic Research Group was able to achieve the flexibility needed to span multiple therapeutic areas and eliminate redundancy in documentation.

  2. How Heron Therapeutics Sped Up Database Creation 12/2/2022

    Electronic data capture (EDC) is straightforward, in theory. However, not every EDC is purpose-designed for ease of use by study teams, and some are easier to use and more intuitive than others.

  3. Rely On ePRO And EDC For Easier Cleaner Data 10/11/2022

    What makes a clinical trials software provider a good fit? How do you make the decision to use a particular electronic data capture (EDC) system or electronic patient reported outcome (ePRO) solution? Learn how the answers are different for every sponsor and contract research organization (CRO).

  4. Sciformix Finds An eClinical Ally In Medrio 10/3/2022

    Sciformix, an SPO (Scientific Process Organization) serving a diverse variety of clinical trials across all phases, has built substantial experience in Medrio in a short span of time. Find out how Medrio helped Sciformix reduce the cost and timeline of the study.

  5. Digital Medicine Society Accelerates Recruitment and Results With eConsent 9/26/2022

    Find out how the Digital Medicine Society (DiMe), an interdisciplinary professional society for digital medicine, was able to deploy an eConsent module in less than two weeks to support its remote study to assess nocturnal scratching as an endpoint for patients.

  6. TargetCancer Foundation Successfully Engages And Empowers Rare Cancer Patients 9/13/2022

    Delve into how the TargetCancer Foundation implemented a remote consent function in their TCF-001 TRACK study with an objective to determine if rare tumors can benefit from matched molecular therapy.

  7. Achieving 97% Patient Compliance, Increased Patient Engagement 9/23/2021

    In a proof-of-concept for a decentralized hybrid study, explore how Electronic Patient-Reported Outcomes (ePRO) technology was used to assess the results of varying digital therapies and the feasibility of conducting a largely virtual clinical study in a fibromyalgia population.